Orion, Novartis Settle Patent Dispute Over Sedation Drug

Law360, New York (December 6, 2013, 5:58 PM EST) -- Orion Corp. and Hospira Inc. have reached a settlement with Sandoz Inc. in a suit in the Federal Circuit accusing the Novartis AG unit of infringing Orion’s patent on sedation drug Precedex, agreeing to allow Sandoz to launch its version of the drug next year, Hospira announced Thursday.

The settlement permits Sandoz to launch its generic version of Precedex next December. The complaint, first filed in 2009, accuses the company of violating Orion’s U.S. Patent No. 4,910,214 and Orion’s and Hospira’s jointly owned U.S. Patent No....
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.